Neuroendocrine Tumor (NET) of the Appendix — Therapy With Lutetium-177-DOTATATE (Lu-177): treatment in Berlin - Germany
Treatment prices are regulated by national law of the corresponding countries, but can also include additional hospital coefficients. In order to receive the individual cost calculation, please send us the request and medical records.
Department of Nuclear Medicine
The Department of Nuclear Medicine offers the full range of diagnostic and therapeutic procedures using modern radioactive substances. The diagnostic options include scintigraphic studies of the lungs, heart, brain, kidneys, lymph nodes, bones, including in small patients. In the field of therapy, one of the priority focuses is the use of radioiodine therapy for thyroid pathologies. Medical care and patient care are provided by highly qualified doctors and nursing staff who believe that the health and wellbeing of their patients is a top priority.
Department of Nuclear Medicine
According to the Focus magazine, the Department of Nuclear Medicine is ranked among the best medical facilities with such specialization in Germany! The department offers a full range of radioisotope diagnostics and radionuclide treatment. The specialists of the department have a particular interest in the diagnosis and therapy of oncological diseases, pathologies of the nervous system, heart, musculoskeletal system, ENT organs, thyroid diseases, urological and gynecological disorders. The department's physicians provide outpatient diagnostics, inpatient and outpatient treatment in accordance with the standards and recommendations of national and international professional societies. The department is equipped with a complete arsenal of modern technology available in nuclear medicine: all types of scintigraphy are performed here, including whole-body scintigraphy, SPECT, SPECT-CT, PET-CT, PET-MRI. In addition, the department has several radiochemical modules, including a cyclotron for the synthesis of radioactive isotopes for SPECT and PET, as well as for the production of radioisotope preparations. The therapeutic spectrum of services offered by the department includes PSMA therapy for the treatment of metastatic prostate cancer, peptide receptor radionuclide therapy for the treatment of neuroendocrine tumors, selective internal radiation therapy for the treatment of primary liver tumors and liver metastases, and other advanced radionuclide therapies. The department annually provides medical care to more than 15,000 patients, which confirms the high reputation of the clinic among medical institutions in Germany with such specialization.
